Clinical trial
sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?
NCT04394195 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?
- Lead sponsor
- CHU de Reims
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 3, 2020
- Completion date
- September 1, 2020
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.